Metropolitan Life Insurance Company (MetLife)’s IDEAYA Biosciences IDYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,460
| Closed | -$152K | – | 1009 |
|
|
2024
Q1 | $152K | Buy |
3,460
+29
| +0.8% | +$1.27K | 0.01% | 829 |
|
|
2023
Q4 | $122K | Buy |
3,431
+293
| +9% | +$10.4K | 0.01% | 968 |
|
|
2023
Q3 | $84.7K | Buy |
3,138
+170
| +6% | +$4.59K | ﹤0.01% | 1100 |
|
|
2023
Q2 | $69.7K | Buy |
2,968
+638
| +27% | +$15K | ﹤0.01% | 1220 |
|
|
2023
Q1 | $32K | Sell |
2,330
-413
| -15% | -$5.67K | ﹤0.01% | 1636 |
|
|
2022
Q4 | $49.8K | Buy |
2,743
+774
| +39% | +$14.1K | ﹤0.01% | 1480 |
|
|
2022
Q3 | $29.4K | Hold |
1,969
| – | – | ﹤0.01% | 1807 |
|
|
2022
Q2 | $27.2K | Hold |
1,969
| – | – | ﹤0.01% | 1886 |
|
|
2022
Q1 | $22K | Sell |
1,969
-6,374
| -76% | -$71.3K | ﹤0.01% | 2044 |
|
|
2021
Q4 | $197K | Hold |
8,343
| – | – | ﹤0.01% | 2038 |
|
|
2021
Q3 | $213K | Hold |
8,343
| – | – | ﹤0.01% | 2016 |
|
|
2021
Q2 | $175K | Buy |
8,343
+2,697
| +48% | +$56.6K | ﹤0.01% | 2247 |
|
|
2021
Q1 | $133K | Buy |
+5,646
| New | +$133K | ﹤0.01% | 2288 |
|